PHILIP GREEN, deputy secretary and registrar, Royal Pharmaceutical Society, replies:

I welcome this feedback. It is early days for the two-part Register. We could restrict the mailing list for items such as professional communications, safety notices, etc, from the government to the practising part of the Register. However, not all those members on the non-practising part are permanently retired and, indeed, not all the permanently retired will wish to be excluded from sources of information. Some like to read and write to The Pharmaceutical Journal, for example. Moreover, many on the non-practising part of the Register are on maternity leave or career breaks and may find such information will help ensure they are not unaware of something they may need to know when they return to practice. This is the only comment we have received on this matter and we would be interested in other views — for or against.